Effect of intimate hygiene fluids on the number of Listeria monocytogenes isolated from women
, 1, 1, 2, 1, 1, 1, , 1
Abstract
Introduction. Listeria monocytogenes is an etiological factor of listeriosis, widespread in the environment. The consequence of fetal infection in the second trimester of pregnancy in most cases is the death of the fetus or stillbirth.
Material and methods. In this study, 7 strains of L. monocytogenes isolated from the vagina of women and the reference strain L. monocytogenes ATCC 19111 were used. The examined strains were treated with five commercially available intimate hygiene washes. The efficacy of the wash fluids used was based on the induced decrease in the number of bacteria expressed as a logarithmic colony-forming unit (CFU) × ml-1.
Results. The study showed that probiotic fluid (pH = 3.5) decreased the number of bacteria by an average of 4.56 log CFU × ml-1, while wash fluid intended for pregnant and puerperal women (pH = 4.0) reduced the number of L. monocytogenes by an average of 1.55 log CFU × ml-1. Lower bactericidal efficacy was observed in the case of wash fluids intended for everyday use. The fluid containing marigold extract and the liquid with the addition of rice proteins and arnica extract decreased the number of L. monocytogenes by an average of 1.11 log CFU × ml-1, and the fluid with silver and copper nanoparticles by 1.14 log CFU × ml-1.
Conclusions. Everyday use of intimate hygiene washes reduces the risk of urogenital infections in women and supports their treatment. Prevention with the use of probiotic wash solutions may reduce the number of vaginal infections caused by L. monocytogenes, which is especially important in the case of pregnant women because the number of patients diagnosed with listeriosis has increased.
Keywords: intimate hygiene fluidsListeria monocytogenesvaginal infectionslisteriosis in pregnancy
References
- Jurkiewicz A, Oleszczak-Momot W. Listeria monocytogenes jako problem zdrowia publicznego. Med Og Nauk Zdr. 2015; 21(1): 29–32.
- Schlech FW. Epidemiology and clinical manifestations of Listeria monocytogenes infections. In: Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J. ed. Gram-Positive Pathogens Vol. 2. ASM Press, Washington 2006: 601–608.
- Boroń-Kaczmarska A. Zakażenia u ciężarnych – czy TORCH nadal jest dominujący? Zakażenia XXI w. 2019; 2(3): 107–113.
- Borges SF, Silva JGL, Teixeira PCM. Survival and biofilm formation of Listeria monocytogenes in simulated vaginal fluid: influence of pH and strain origin. FEMS Immunol Med Microbiol. 2011; 62(3): 315–320.
- Posfay-Barbe KM, Wald ER, et al. Listeriosis. Semin Fetal Neonatal Med. 2009; 14(4): 228–233.
- Krajowy Ośrodek Referencyjny ds. Diagnostyki Bakteryjnych Zakażeń Ośrodkowego Układu Nerwowego: Listerioza w Polsce w latach 2011 - 2015 Warszawa, 17.03.2016.
- Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food--10 states, 2007. MMWR Morb Mortal Wkly Rep. 2008; 57(14): 366–370.
- Madjunkov M, Chaudhry S, Ito S. Listeriosis during pregnancy. Arch Gynecol Obstet. 2017; 296(2): 143–152.
- NIZP-PZH. Choroby zakaźne i zatrucia w Polsce. Warszawa (Poland): Narodowy Instytut Zdrowia Publicznego – Państwowy Zakład Higieny. 2019.
- Atassi F, Brassart D, Grob P, et al. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunol Med Microbiol. 2006; 48(3): 424–432.
- Bodaszewska-Lubas M, Brzychczy-Wloch M, Gosiewski T, et al. Antibacterial activity of selected standard strains of lactic acid bacteria producing bacteriocins--pilot study. Postepy Hig Med Dosw (Online). 2012; 66: 787–794.
- Chen Y, Bruning E, Rubino J, et al. Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage. Womens Health (Lond). 2017; 13(3): 58–67.
- Sieroszewski P, Bober Ł, Kłosński W. Zakażenia podczas ciąży. Perinatol Neonatol Ginekol. 2012; 5(2): 65–84.
- Wysocka-Lipińska N, Tkachenko H, Kurhaluk N. Ocena skuteczności chusteczek antybakteryjnych. Słupskie Prace Biologiczne. 2012; 9: 181–196.
- Chen M, Pan X, Wu H, et al. Preparation and anti-bacterial properties of a temperature-sensitive gel containing silver nanoparticles. Pharmazie. 2011; 66(4): 272–277.
- Tamayo LA, Zapata PA, Vejar ND, et al. Release of silver and copper nanoparticles from polyethylene nanocomposites and their penetration into Listeria monocytogenes. Mater Sci Eng C Mater Biol Appl. 2014; 40: 24–31.
- Bahamondes MV, Portugal PM, Brolazo EM, et al. Use of a lactic acid plus lactoserum intimate liquid soap for external hygiene in the prevention of bacterial vaginosis recurrence after metronidazole oral treatment. Rev Assoc Med Bras (1992). 2011; 57(4): 415–420.
- Białobrzeska P. Profilaktyka zakażeń układu moczowego u pacjentów po przeszczepie nerki. Forum Nefrol. 2011; 4(3): 266–271.
- Bruning E, Chen Y, McCue KA, et al. A 28 Day Clinical Assessment of a Lactic Acid-containing Antimicrobial Intimate Gel Wash Formulation on Skin Tolerance and Impact on the Vulvar Microbiome. Antibiotics (Basel). 2020; 9(2).
- Pawłowska K. Wpływ liczby szczepów bakterii Lactobacillus na skuteczność probiotyku ginekologicznego. http://docplayer.pl/6108076-Wplyw-liczby-szczepow-bakterii-lactobacillus-na-skutecznosc-probiotyku-ginekologicznego.html (19.06.2021).
- Harasim-Dylak A, Roguska M, Maździarz A. Skuteczność preparatu Trivagin w przywróceniu i utrzymaniu prawidłowego ekosystemu pochwy u kobiet leczonych z powodu nawracającej waginozy bakteryjnej. Curr Gynecol Oncol. 2011; 9(4): 245–252.